Opening Recap
Market Pulse: Tech and biotech outperformed, sending indices into green; Micron’s strong guide and Phase 3 trial wins fueled a broad rally.
Key Movers: Micron (MU) flexed its muscle with an earnings beat (Yahoo Entertainment), China Medical System lit a fuse with its ruxolitinib cream trial success (GlobeNewswire), and Evkeeza alongside PALSONIFY claimed fresh FDA approvals.
Macro & Politics: Grassroots activists, highlighted in “Community Is as Important to the Fight for Democracy” (Ms. Magazine), are poised to push D.C. into surprise tax and regulatory shifts that could jolt markets.
What’s Next: Watch for more FDA rulings and potential merger filings; any swing in crypto sentiment could spark a mini short squeeze before the bell.
Market Commentary
What everyone’s missing is the risk buried in deal frenzy. Leif Larson’s “The Art Of A Bad Railroad Merger Deal” (The Daily Caller) warns that consolidation can blow up when power concentrates in too few hands. Yet traders are hyping Harrow’s bid for Melt Pharmaceuticals without a second thought for antitrust roadblocks or integration snags—ask yourself if that spread is worth the gamble.
Watching Bitcoin edge higher (CoinDesk) while Evkeeza and PALSONIFY clear FDA hurdles feels disconnected until you realize liquidity chases certainty. When crypto sentiment slides into fear territory, money rotates to defensive biotech names with hard binary wins. That flip-flop could fuel a dead-cat bounce in coins before the real action resumes.
Load up on names with upcoming catalysts—keep an eye on Micron for any guide tweaks and Harrow/Melt merger developments. Trim exposure ahead of D.C.’s next policy ambush, and brace for volatility in both equity and crypto markets. This is your edge—use it.
📈 Breaking Financial News
Micron (MU) Delivers Earnings Beat and Strong Forecast, Stock Outlook Brightens
Micron Technology, Inc. (NASDAQ:MU) is one of the AI Stocks Every Investor Should Watch. On September 24, Barclays analyst Tom O’Malley raised the price…
LEIF LARSON: The Art Of A Bad Railroad Merger Deal
The merger is not a good idea because it would concentrate too much power in two railroad companies.
Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH) HoFH is an inherited condition……
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rap…
Crinetics announces FDA approval of PALSONIFY
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
You WILL buy these four miners [now or when the herd panics]
BREAKING: The Senate just passed Trump’s “Big Beautiful Bill” – which guarantees the US will add another $10 trillion to its already massive debt pile. The means big beautiful gains are coming to the best gold miners – because gold runs higher and longer in times of out of control monetary inflation. Go here to learn about the four “Golden Anomaly” miners selling at discounts up to 90% below the value of their gold in the ground
🔍 Market Analysis & Insights
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is app…
99 Problems: Why Ben & Jerry's is at war with Unilever
The man who put ‘Jerry' into ‘Ben & Jerry's' has walked away from the company he co-founded in a dispute that many industry-watchers predicted 25 years ago, writes Adam Maguire.
Bitcoin Edges Higher, ETH Rebounds Above $4k as Sentiment Slips Into ‘Fear' Territory
PCE inflation data matched analysts expectation, but leaves policymakers balancing sticky inflation with a softer labor market, one Sygnum Bank's CIO noted.
Community Is as Important to the Fight for Democracy as Everything Else
It has been a hell of a week for gridlock in my hometown, New York City, as global leaders convene for the 80th United Nations General Assembly —where on Monday, President Donald Trump delivered an hour-long rant calling climate change a hoax and claiming to h…
Pundit Says Bitcoin Is Still In A Bull Market Despite Price Crash; Here’s Why
Bitcoin has experienced a sharp price drop in recent days, but one well-followed crypto analyst remains undaunted. Popular chartist Egrag Crypto says Bitcoin is still in a bull market, even with the pullback. He believes what is happening now is only part of …
Trump's “New Golden Age” Tech to Create $12 Trillion Boom?
Trump's about to prove everybody wrong. He's been ridiculed for his moves in the trade war… But everything is about to make perfect sense the moment people see Trump's “New Golden Age” tech. Because this little-known technology could ignite a $12 trillion manufacturing revolution… And early investors could see stratospheric gains. Click here to discover Trump's tech.
💰 Investment Opportunities
SCGJWD Logistics implements roadmap further expanding cold storage investment base from CLMV + China to high-growth ASEAN countries
SCGJWD Logistics PCL (SET: SJWD), the largest integrated logistics and supply chain service provider in ASEAN, is further expanding its cold storage warehouse …
Harrow to Acquire Melt Pharmaceuticals
NASHVILLE, Tenn., Sept. 26, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into an agreement to acquire Melt Pharmaceuticals, Inc., a clinical…
United States Wound Care Market Report 2025-2033: Key States Like California, Texas, New York, and Florida Highlight Diverse Regional Growth Driven by Demand for Advanced Wound Management Solutions
The United States Wound Care Market is projected to grow from $6.45 billion in 2024 to $10.4 billion by 2033, driven by a 5.44% CAGR from 2025-2033. Factors such as rising chronic wounds, technological advancements, and the aging population are key drivers of…
Best Fat Burner for Men- Effective Men’s Fat Burning Supplements- Wolfsan Brand launch 2025
In 2025, Wolfson Brands has unveiled an advanced line of Best fat-burning supplements for man designed to align with the evolving needs of modern lifestyles. Today, fat management is far from a one-size-fits-all challenge. In 2025, Wolfson Brands has unveiled…
Twenty-Five Years of RU-486: How Activists Brought the Abortion Pill to America and Changed Reproductive Health Forever
At the urging of antiabortion advocates and politicians, and based on a flawed and biased report put out by an antiabortion group, the Trump administration announced the launch of a new review of mifepristone, despite 100 peer-reviewed scientific studies prov…
Is This Tiny Town the Key to the AI Revolution?
Loudoun County, Virginia. Population: exploding. Wealth: Concentrated. Secret: A $20 company that's vital to the future of AI. Dylan Jovine's urgent briefing reveals how you can profit.